The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices

Epilepsy Research

Volumn 59, Issue 2-3, 2004, Pages 83-94

  Laudadio, Mark Anthony ^a   Psarropoulou, Caterina ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

8 cyclopentyl 1,3 dipropylxanthine; ACSF; artificial cerebrospinal fluid; bicuculline methiodide; BMI; DPCPX; fEPSP; field excitatory postsynaptic potential; NBTI; nitrobenzylthioinosine; P; population spike; postnatal day; PS; S.E.M.; standard error of mean

Indexed keywords

1 [2 CHLORO 6 [[(3 IODOPHENYL)METHYL]AMINO] 9H PURIN 9 YL] 1 DEOXY N METHYL BETA DEXTRO RIBOFURANURONAMIDE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; BICUCULLINE; NITROBENZYLTHIOINOSINE; UNCLASSIFIED DRUG; 2 CHLORO N(6) (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 2-CHLORO-N(6)-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE; ADENOSINE; DRUG DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; EPILEPTIC DISCHARGE; EVOKED RESPONSE; EXCITATION; FREQUENCY ANALYSIS; FREQUENCY MODULATION; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; ACTION POTENTIAL; ANIMAL; DRUG POTENTIATION; EPILEPSY; IN VITRO STUDY; METABOLISM; NEWBORN; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ADENOSINE; ANIMALS; ANIMALS, NEWBORN; EPILEPSY; HIPPOCAMPUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A3;

EID: 3042813743     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2004.03.005     Document Type: Article

References (44)

1. Abbracchio M.P., Ceruti S., Brambilla R., Franceschi C., Malorni W., Jacobson K.A., von Lubitz D.K., Cattabeni F. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders. Ann. N. Y. Acad. Sci. 825:1997;11-22
2. Adami M., Bertorelli R., Ferri N., Foddi M.C., Ongini E. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat. Eur. J. Pharmacol. 294(2/3):1995;383-389
3. Alzheimer C., Sutor B., ten Bruggencate G. Disinhibition of hippocampal CA3 neurons induced by suppression of an adenosine A1 receptor-mediated inhibitory tonus: pre- and postsynaptic components. Neuroscience. 57(3):1993;565-575
4. Cunha R., Constantino M., Ribeiro J. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br. J. Pharamacol. 122(7):1997;1279-1284
5. 2a receptors in the rat hippocampus. Brain Res. 649:1994;208-216
6. Cunha R., Ribeiro J. Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals. Neuropharmacology. 39(7):2000;1156-1167
7. Daval J.-L., Werck M.C., Nehling A., deVasconcelos A.P. Quantitative autoradiographic study of the postnatal development of adenosine A1 receptors and their coupling to G proteins in the rat brain. Neuroscience. 40(3):1991;841-851
8. De Sarro G., De Sarro A., Di Paola E.D., Bertorelli R. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur. J. Pharmacol. 371(2/3):1999;137-145
9. Deckert J., Bisserbe J.-C., Klein E., Marangos P. Adenosine uptake sites in brain: regional distribution of putative subtypes in relationship to adenosine A1-receptors. J. Neurosci. 8(7):1988;2338-2349
10. Descombes S., Avoli M., Psarropoulou C. A comparison of the adenosine-mediated synaptic inhibition in the CA3 area of immature and adult rat hippocampus. Dev. Brain Res. 110:1998;51-59
11. Dunwiddie, T.V., 1999. Adenosine and suppression of seizures. In: Delgado-Escueta, A., Wilson, W., Olsen, R., Porter, R. (Eds.), Advanced Neurology, vol. 79. Lippincott Williams & Wilkins, Philadelphia, pp. 1001-1010.
12. Dunwiddie T.V., Diao L., Kim H.O., Jiang J.L., Jacobson K.A. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J. Neurosci. 17(2):1997;607-614
13. Fleming K., Mogul D. Adenosine A3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway. Neuropharmacology. 36(3):1997;353-362
14. Fredholm B. Adenosine and neuroprotection. Int. Rev. Neurobiol. 40:1997;259-280
15. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn-Schmiedebergs Arch. Pharmacol. 362(4/5):2000;364-374
16. Galvan C., Hrachovy R., Smith K., Swann J. Blockade of neuronal activity during hippocampal development produces a chronic focal epilepsy in the rat. J. Neurosci. 20(8):2000;2904-2916
17. Greene R.W., Haas H.L., Hermann A. Effects of caffeine on hippocampal pyramidal cells in vitro. Br. J. Pharmacol. 85:1985;163-169
18. Haas H., Greene R. Endogenous adenosine inhibits hippocampal CA1 neurones: further evidence from extra- and intracellular recording. Naunyn-Schmiedebergs Arch. Pharmacol. 337:1988;561-565
19. Huber A., Guttinger M., Mohler H., Boison D. Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci. Lett. 329(3):2002;289-292
20. 3 adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future. 20:1995;689-699
21. Jacobson K.A. Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol. Sci. 19(5):1998;184-191
22. Keddie J.R., Poucher S.M., Shaw G.R., Brooks R., Collis M.G. In vivo characterisation of ZM-241385, a selective adenosine A2A receptor antagonist. Eur. J. Pharmacol. 301(1-3):1996;107-113
23. Kessey K., Mogul D.J. Adenosine A2 receptors modulate hippocampal synaptic transmission via a cyclic-AMP-dependent pathway. Neuroscience. 84(1):1998;59-69
24. Kessey K., Trommer B.L., Overstreet L.S., Ji T., Mogul D.J. A role for adenosine A2 receptors in the induction of long-term potentiation in the CA1 region of rat hippocampus. Brain Res. 756(1/2):1997;184-190
25. Li H., Henry J. Adenosine A2 mediation of pre- and postsynaptic excitatory effects of adenosine in rat hippocampus in vitro. Eur. J. Pharmacol. 347(2/3):1998;173-182
26. Lin Y., Phillis J. Characterization of the depression of rat cerebral cortical neurons by selective adenosine agonists. Brain Res. 540:1991;307-310
27. Macek T.A., Schaffhauser H., Conn P.J. Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J. Neurosci. 18(16):1998;6138-6146
28. Morgan P., Montgomery P., Marangos P. Ontogenetic profile of the adenosine uptake sites in rat forebrain. J. Neurochem. 49:1987;852-855
29. Moshé S. Epileptogenesis and the immature brain. Epilepsia. 28(Suppl. 1):1987;S3-S15
30. Park T., Wylen D.V., Rubio R., Berne R. Increased brain interstitial fluid adenosine concentration during hypoxia in newborn piglet. J. Cereb. Blood Flow Metab. 7:1987;178-183
31. Psarropoulou C., Avoli M. Developmental features of 4-aminopyridine induced epileptogenesis. Dev. Brain Res. 94:1996;52-59
32. Psarropoulou C., Boivin M., Laudadio M.A. Nicotinic effects on excitatory field potentials recorded from the immature CA3 area of rat hippocampal slices. Exp. Brain Res. 152(3):2003;353-360
33. A-mediated inhibition induces synchronous epileptiform activity in immature rat hippocampus. Neuroscience. 82(4):1998;1067-1077
34. Psarropoulou C., Descombes S. Differential bicuculline-induced epileptogenesis in rat neonatal, juvenile and adult CA3 pyramidal neurons in vitro. Dev. Brain Res. 117(1):1999;117-120
35. Psarropoulou C., Kostopoulos G., Haas H.L. An electrophysiological study of the ontogenesis of adenosine receptors in the CA1 area of the rat hippocampus. Dev. Brain Res. 55:1990;147-150
36. Rudolphi K., Schubert P., Parkinson F., Fredholm B. Neuroprotective role of adenosine in cerebral ischemia. TIPS. 13:1992a;439-445
37. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4(4):1992b;346-369
38. Sanderson G., Scholfield C. Effects of adenosine uptake blockers and adenosine on evoked potentials of guinea-pig olfactory cortex. Pflug. Arch. 406:1986;25-30
39. 1-receptors with DPCPX enhances stimulus train-evoked neuronal Ca influx in rat hippocampal slices. Brain Res. 458:1988;162-165
40. 2 adenosine receptors in the rat hippocampus. Neurosci. Lett. 138:1992;41-44
41. 2A receptor enhances GABAA-mediated IPSPs in the globus pallidus. Soc. Neurosci. Abstr. 25:2000;418-431
42. Sutor B., Hablitz J.J., Rucker F., ten Bruggencate G. Spread of epileptiform activity in the immature rat neocortex studied with voltage-sensitive dyes and laser scanning microscopy. J. Neurophysiol. 72(4):1994;1756-1768
43. Von Lubitz D.K., Lin R.C., Popik P., Carter M.F., Jacobson K.A. Adenosine A3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263(1/2):1994;59-67
44. Von Lubitz D.K.J.E. Adenosine A3 receptor and brain: aculprit, a hero, or merely yet an other receptor. Ann. N. Y. Acad. Sci. 825:1997;49-67